Publications

The impact of alternative delivery strategies for novel tuberculosis vaccines in low- and middle-income countries: a modelling study.

Clark, R; Mukandavire, C; Portnoy, A; WEERASURIYA, C; Deol, A; Scarponi, D; Iskauskas, A; Bakker, R; Quaife, M; Malhotra, S; Gebreselassie, N; Zignol, M; Hutubessy, RC W; Giersing, B; JIT, M; Harris, R; Menzies, N; WHITE, R;

2022

medRxiv (2022). 10.1101/2022.04.16.22273762.

Effectiveness of case-area targeted interventions including vaccination on the control of epidemic cholera: protocol for a prospective observational study.

RATNAYAKE, R; Peyraud, N; Ciglenecki, I; Gignoux, E; Lightowler, M; Azman, AS; Gakima, P; Ouamba, JP; Sagara, JA; Ndombe, R; Mimbu, N; Ascorra, A; Epicentre and MSF CATI Working Group,; Welo, PO; Mukamba Musenga, E; Miwanda, B; Boum, Y; CHECCHI, F; EDMUNDS, WJ; Luquero, F; Porten, K; Finger, F;

2022

BMJ Open, (2022).12 7 10.1136/bmjopen-2022-061206.

Cost-effectiveness of routine adolescent vaccination with an M72/AS01E-like tuberculosis vaccine in South Africa and India.

Harris, RC; QUAIFE, M; WEERASURIYA, C; Gomez, GB; SUMNER, T; BOZZANI, F; WHITE, RG;

2022

Nature Communications, (2022).13 1 10.1038/s41467-022-28234-7.

Human papillomavirus vaccine communication materials for young people in English-speaking countries: A content analysis.

Fisher, H; CHANTLER, T; MOUNIER-JACK, S; Audrey, S;

2022

Health education journal, (2022).81 5 10.1177/00178969221092135.

Data for: 'BCG revaccination in Malawi: 30-year follow-up of a large, randomised, double-blind placebo-controlled trial'.

GLYNN, JR; FIELDING, K; Mzembe, T; Sichali, L; Banda, L; MCLEAN, E; Kanjala, C; CRAMPIN, AC; Ponnighaus, J; Warndorff, D; FINE, P;

2021

, London School of Hygiene & Tropical Medicine (London, United Kingdom) (2021). 10.17037/DATA.00002443.

Monitoring global trends in Covid-19 vaccination intention and confidence: a social media-based deep learning study.

Zhou, X; DE FIGUEIREDO, A; Xu, Q; LIN, L; Kummervold, P; Larson, H; JIT, M; Hou, Z;

2021

medRxiv (2021). 10.1101/2021.04.17.21255642.

The effect of new Mycobacterium tuberculosis infection on the sensitivity of prognostic TB signatures.

SUMNER, T; Fiore-Gartland, A; Hatherill, M; HOUBEN, RM G J; Scriba, TJ; WHITE, RG;

2021

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, (2021).25 12 10.5588/ijtld.21.0323.

SARS-CoV-2 infection risk during delivery of childhood vaccination campaigns: a modelling study.

PROCTER, SR; ABBAS, K; FLASCHE, S; Griffiths, U; Hagedorn, B; O'REILLY, KM; CMMID COVID-19 Working Group,; JIT, M;

2021

BMC Medicine, (2021).19 1 10.1186/s12916-021-02072-8.

Comparative effectiveness of allocation strategies of COVID-19 vaccines and antivirals against emerging SARS-CoV-2 variants of concern in East Asia and Pacific region.

Leung, K; JIT, M; Leung, G; Wu, J;

2021

medRxiv (2021). 10.1101/2021.10.20.21265245.

SARS-CoV-2 Variants and Vaccines.

Krause, PR; Fleming, TR; Longini, IM; Peto, R; Briand, S; HEYMANN, DL; Beral, V; Snape, MD; Rees, H; Ropero, A-M; Balicer, RD; Cramer, JP; Muñoz-Fontela, C; Gruber, M; Gaspar, R; Singh, JA; Subbarao, K; Van Kerkhove, MD; Swaminathan, S; Ryan, MJ; Henao-Restrepo, A-M;

2021

New England Journal of Medicine, (2021).385 2 10.1056/NEJMsr2105280.